asthma pharmacology

Essential role of smooth muscle Rac1 in severe asthma-associated airway remodelling
Florian Dilasser, Lindsay Rose, Dorian Hassoun, Martin Klein, Morgane Rousselle, Carole Brosseau, Christophe Guignabert, Camille Taillé, Marie Christine Dombret, Leonarda Di Candia, Nicolas Heddebaut, Gregory Bouchaud, Marina Pretolani, Antoine Magnan, Gervaise Loirand, Vincent Sauzeau

Thorax Apr 2021, 76 (4) 326-334; DOI: 10.1136/thoraxjnl-2020-216271
Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial
Rubén Andújar-Espinosa, Lourdes Salinero-González, Fátima Illán-Gómez, Manuel Castilla-Martínez, Chunshao Hu-Yang, Francisco José Ruiz-López

Thorax Feb 2021, 76 (2) 126-133; DOI: 10.1136/thoraxjnl-2019-213936
Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy
Shakti D Shukla, Steven L Taylor, Peter G Gibson, Daniel Barker, John W Upham, Ian A Yang, Paul N Reynolds, Sandra Hodge, Alan L James, Geraint B Rogers, Jodie L Simpson

Thorax Jan 2021, thoraxjnl-2020-216331; DOI: 10.1136/thoraxjnl-2020-216331
Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies
Christos V Chalitsios, Dominick E Shaw, Tricia M McKeever

Thorax Jan 2021, 76 (1) 21-28; DOI: 10.1136/thoraxjnl-2020-215664
Association between asthma, corticosteroids and allostatic load biomarkers: a cross-sectional study
Luke Evan Barry, Ciaran O’Neill, Liam G Heaney

Thorax Oct 2020, 75 (10) 835-841; DOI: 10.1136/thoraxjnl-2019-214139
What matters most to patients when choosing treatment for mild–moderate asthma? Results from a discrete choice experiment
Christina Baggott, Paul Hansen, Robert J Hancox, Jo Katherine Hardy, Jenny Sparks, Mark Holliday, Mark Weatherall, Richard Beasley, Helen K Reddel, James Fingleton

Thorax Oct 2020, 75 (10) 842-848; DOI: 10.1136/thoraxjnl-2019-214343
CEACAM3 decreases asthma exacerbations and modulates respiratory syncytial virus latent infection in children
Ching-Hui Tsai, Ann Chen Wu, Bor-Luen Chiang, Yao-Hsu Yang, Shih-Pin Hung, Ming-Wei Su, Ya-Jen Chang, Yungling L Lee

Thorax Sep 2020, 75 (9) 725-734; DOI: 10.1136/thoraxjnl-2019-214132
Carbon footprint impact of the choice of inhalers for asthma and COPD
Christer Janson, Richard Henderson, Magnus Löfdahl, Martin Hedberg, Raj Sharma, Alexander J K Wilkinson

Thorax Jan 2020, 75 (1) 82-84; DOI: 10.1136/thoraxjnl-2019-213744
Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study
John Busby, Cecile T J Holweg, Akiko Chai, Peter Bradding, Fang Cai, Rekha Chaudhuri, Adel H Mansur, James Laurence Lordan, John G Matthews, Andrew Menzies-Gow, Robert Niven, Tracy Staton, Liam G Heaney

Thorax Aug 2019, 74 (8) 806-809; DOI: 10.1136/thoraxjnl-2018-212709
Duration of the efficacy of omalizumab after treatment discontinuation in ‘real life’ severe asthma
Maria del Carmen Vennera, Carlos Sabadell, Cesar Picado

Thorax Aug 2018, 73 (8) 782-784; DOI: 10.1136/thoraxjnl-2017-210017

Main menu

asthma pharmacology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

asthma pharmacology

Pages